Cosmo Feilding-Mellen
CIK 2094202 · last filed 2026-01-06
Cosmo Feilding-Mellen is a corporate insider who has filed 5 SEC Form 4 insider transactions across 1 company since 2025. The most recent filing, for ATAI, was dated Mar 11, 2026. Current disclosed insider exposure totals $56.9M across reported positions. 4 SEC filings were submitted jointly with ATAI Life Sciences N.V.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$56.93M
1
5
$0
Filer Profile
AMSTELVEEN 1183
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ATAI | Director | 7,702,990 | $7.39 | $56.93M | $0 | 2 | 2025-11-26 |
Recent Filings
5 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-11 | ATAI | Notice (144) | −750,000 | -$2.99M | EDGAR |
| 2026-02-26 | — | Notice (144) | −750,000 | -$3.00M | EDGAR |
| 2026-01-06 | — | Sell (S) | −39,594 | -$154.4K | |
| 2025-11-26 | ATAI | Mixed | — | $0 | EDGAR |
| 2025-11-06 | ATAI | Grant (A) | +7,702,990 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.